Selective Estrogen Receptor Modulators - A New Adjunctive Treatment for Men with Schizophrenia?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1042429

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

One-third of people with schizophrenia do not respond well to antipsychotic medication treatment.There is an urgent need to develop new treatments.We have conducted world-first studies showing that estrogen treatment is highly successful in treating women with schizophrenia.Our research is a trial of SERM (selective estrogen receptor modulator), a new form of “brain estrogen” in men with persistent schizophrenia. We hope to reduce the disability caused by persistent psychotic symptoms.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $816,603.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antipsychotic drugs | hormones | men's health | quality of life | schizophrenia

Related Links